MedPath

The Effect of Sildenafil Citrate on the Success Rate of Ovulation Induction Using Clomiphene

Phase 2
Completed
Conditions
Anovulatory
Interventions
Registration Number
NCT02663830
Lead Sponsor
Ain Shams University
Brief Summary

The aim of the study is to evaluate the effect of sildenafil citrate on the pregnancy rate in women undergoing induction of ovulation using clomiphene citrate.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
210
Inclusion Criteria
  • Women age 21-35 years.
  • Anovulatory cycles due to polycystic ovaries syndrome.
  • Non-smokers.
  • Free of major medical illness
Exclusion Criteria
  • Women with myoma or adenomyosis
  • Women with congenital uterine anomaly.
  • Chronic use of any medications including non-steroidal anti-inflammatory drugs.
  • Associated cases of infertility other than PCOs (male factor, tubal factor,....).
  • Asherman syndrome.
  • Cases with endometrial hyperplasia.
  • Cases with endometrial polyp

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
(Sildenafil & clomiphene citrate group)Sildenafil & clomiphene citrate105 Patients will receive 25 mg sildenafil citrate 6 hourly orally (day 6 to the end of the cycle), and clomiphene citrate 100 mg/day (day 2 to 6) orally by the patient, for induction of ovulation
clomiphene onlyclomiphene only105 patients will receive only clomiphene citrate 100mg/day (day 2 to 6) orally (2 tablets at same time daily).
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy rate6 weeks
Secondary Outcome Measures
NameTimeMethod
miscarriage rate13 weeks
endometrial thickness2 weeks
Side Effects of Vasodilators4 weeks
ectopic pregnancy rate8 weeks
© Copyright 2025. All Rights Reserved by MedPath